Go Ad-Free
    My Alerts
    VICTORIS
    Budget Express 2026

    co-presented by

    • LIC
    • JIO BlackRock

    ASSOCIATE SPONSORS

    • Sunteck
    • SBI
    • Emirates
    • Dezerv

    Astellas Pharma

    Jump to
    • Lupin Japanese arm in deal with Astellas to sell antidepressant

      Lupin Japanese arm in deal with Astellas to sell antidepressant

      Astellas submitted a new drug application (NDA) with the Ministry of Health, Labour and Welfare in Japan for extended-release tablets of quetiapine fumarate for the indication of improvement of depressive symptoms associated with bipolar disorder.

    • Nikkei tops 20,000 for 1st time in 15 yrs; up 2.4% on week

      Nikkei tops 20,000 for 1st time in 15 yrs; up 2.4% on week

      The rally has been driven by many factors, including hopes of higher shareholder returns, a rise in corporate earnings, a recovery in domestic consumption and more share buying, both real and imagined, by Japanese public investors.

    • Glenmark settles patent suit with Triax over generic drug

      Glenmark settles patent suit with Triax over generic drug

      Glenmark Pharmaceuticals' USA unit has entered into a royalty-bearing license agreement with Triax Pharmaceuticals, Astellas Pharma Europe BV and Astellas Pharma International BV to settle last year's patent infringement suit against the comercialisation of generic version of Locoid Lipocream, the company said in a press release Wednesday.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347